The estimated Net Worth of John J Alam is at least $68.3 Milion dollars as of 1 October 2008. John Alam owns over 4,253 units of Vertex Pharmaceuticals stock worth over $66,959,703 and over the last 21 years John sold VRTX stock worth over $1,370,325.
John has made over 31 trades of the Vertex Pharmaceuticals stock since 2005, according to the Form 4 filled with the SEC. Most recently John exercised 4,253 units of VRTX stock worth $57,968 on 1 October 2008.
The largest trade John's ever made was selling 32,500 units of Vertex Pharmaceuticals stock on 7 May 2007 worth over $994,175. On average, John trades about 3,600 units every 24 days since 2003. As of 1 October 2008 John still owns at least 141,045 units of Vertex Pharmaceuticals stock.
You can see the complete history of John Alam stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 01239.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden oraz Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: